Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4217)
All Articles published online
|
Jun 28, 2011 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shi CJ, Gao J, Wang M, Wang X, Tian R, Zhu F, Shen M, Qin RY. CD133+ gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity. World J Gastroenterol 2011; 17(24): 2965-2971 [PMID: 21734809 DOI: 10.3748/wjg.v17.i24.2965] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i24/2965.htm |
| Number | Citing Articles |
| 1 |
Md. Motarab Hossain, Naren L. Banik, Swapan K. Ray. Synergistic anti-cancer mechanisms of curcumin and paclitaxel for growth inhibition of human brain tumor stem cells and LN18 and U138MG cells. Neurochemistry International 2012; 61(7): 1102 doi: 10.1016/j.neuint.2012.08.002
|
| 2 |
Ze-Bin Jiang, Bing-Qiang Ma, Zongfeng Feng, Shao-Guang Liu, Peng Gao, Hui-Ting Yan. miR-365 inhibits the progression of gallbladder carcinoma and predicts the prognosis of Gallbladder carcinoma patients. Cell Cycle 2021; 20(3): 308 doi: 10.1080/15384101.2021.1874694
|
| 3 |
Zhong Li. CD133: a stem cell biomarker and beyond. Experimental Hematology & Oncology 2013; 2(1) doi: 10.1186/2162-3619-2-17
|
| 4 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_147-1
|
| 5 |
Xingzhou Yan, Pinghua Yang, Hu Liu, Yongyang Zhao, Zhixiong Wu, Baohua Zhang. miR-4461 inhibits the progression of Gallbladder carcinoma via regulating EGFR/AKT signaling. Cell Cycle 2022; 21(11): 1166 doi: 10.1080/15384101.2022.2042775
|
| 6 |
Shinsuke Nakashima, Shogo Kobayashi, Hiroaki Nagano, Akira Tomokuni, Yoshito Tomimaru, Tadafumi Asaoka, Naoki Hama, Hiroshi Wada, Koichi Kawamoto, Shigeru Marubashi, Hidetoshi Eguchi, Yuichiro Doki, Masaki Mori. BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer. Cancer Science 2015; 106(5): 584 doi: 10.1111/cas.12652
|
| 7 |
Deepika Singh, Dipanjan Biswas, Mallika Tewari, Amrita Ghosh Kar, Mumtaz Ahmad Ansari, Sunita Singh, Gopeshwar Narayan. Clinical Significance of Overexpression of Oct4 in Advanced Stage Gallbladder Carcinoma. Journal of Gastrointestinal Cancer 2023; 54(4): 1231 doi: 10.1007/s12029-023-00913-8
|
| 8 |
Wei Zhou, Yongfeng Li, Shanmiao Gou, Jiongxin Xiong, Heshui Wu, Chunyou Wang, Haijiao Yan, Tao Liu. MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway. Oncotarget 2015; 6(35): 37557 doi: 10.18632/oncotarget.5317
|
| 9 |
Kshitij Srivastava, Anvesha Srivastava, Balraj Mittal. Potential biomarkers in gallbladder cancer: present status and future directions. Biomarkers 2013; 18(1): 1 doi: 10.3109/1354750X.2012.717105
|
| 10 |
Christian Mayr, Tobias Kiesslich, Dominik Paul Modest, Sebastian Stintzing, Matthias Ocker, Daniel Neureiter. Chemoresistance and resistance to targeted therapies in biliary tract cancer: what have we learned?. Expert Opinion on Investigational Drugs 2022; 31(2): 221 doi: 10.1080/13543784.2022.2034785
|
| 11 |
Tajindra Singh Saluja, Murtaza Ali, Prabhaker Mishra, Vijay Kumar, Satyendra Kumar Singh. Prognostic Value of Cancer Stem Cell Markers in Potentially Malignant Disorders of Oral Mucosa: A Meta-analysis. Cancer Epidemiology, Biomarkers & Prevention 2019; 28(1): 144 doi: 10.1158/1055-9965.EPI-18-0672
|
| 12 |
Xin-xing Li, Ying Dong, Wei Wang, Hao-lu Wang, Yu-ying Chen, Gui-ying Shi, Jing Yi, Jian Wang. Emodin As an Effective Agent in Targeting Cancer Stem-Like Side Population Cells of Gallbladder Carcinoma. Stem Cells and Development 2013; 22(4): 554 doi: 10.1089/scd.2011.0709
|
| 13 |
Rajani Rai, Kiran L. Sharma, Swati Tiwari, Sanjeev Misra, Ashok Kumar, Balraj Mittal. DCC (deleted in colorectal carcinoma) gene variants confer increased susceptibility to gallbladder cancer (Ref. No.: Gene-D-12-01446). Gene 2013; 518(2): 303 doi: 10.1016/j.gene.2013.01.019
|
| 14 |
Rohan Manohar, Yaming Li, Helene Fohrer, Lynda Guzik, Donna Beer Stolz, Uma R. Chandran, William A. LaFramboise, Eric Lagasse. Identification of a candidate stem cell in human gallbladder. Stem Cell Research 2015; 14(3): 258 doi: 10.1016/j.scr.2014.12.003
|
| 15 |
Shinji Tanaka. Cancer stem cells as therapeutic targets of hepato-biliary-pancreatic cancers. Journal of Hepato-Biliary-Pancreatic Sciences 2015; 22(7): 531 doi: 10.1002/jhbp.248
|
| 16 |
Elena Vargas-Accarino, Carlos Herrera-Montávez, Santiago Ramón y Cajal, Trond Aasen. Spontaneous Cell Detachment and Reattachment in Cancer Cell Lines: An In Vitro Model of Metastasis and Malignancy. International Journal of Molecular Sciences 2021; 22(9): 4929 doi: 10.3390/ijms22094929
|
| 17 |
Dino Bekric, Daniel Neureiter, Markus Ritter, Martin Jakab, Martin Gaisberger, Martin Pichler, Tobias Kiesslich, Christian Mayr. Long Non-Coding RNAs in Biliary Tract Cancer—An Up-to-Date Review. Journal of Clinical Medicine 2020; 9(4): 1200 doi: 10.3390/jcm9041200
|
| 18 |
Chao Tang, Mengying Ke, Xichao Yu, Shanliang Sun, Xian Luo, Xin Liu, Yanyan Zhou, Ze Wang, Xing Cui, Chunyan Gu, Ye Yang. GART Functions as a Novel Methyltransferase in the RUVBL1/β‐Catenin Signaling Pathway to Promote Tumor Stemness in Colorectal Cancer. Advanced Science 2023; 10(25) doi: 10.1002/advs.202301264
|
| 19 |
Alisa Gisina, Yan Kim, Konstantin Yarygin, Alexey Lupatov. Can CD133 Be Regarded as a Prognostic Biomarker in Oncology: Pros and Cons. International Journal of Molecular Sciences 2023; 24(24): 17398 doi: 10.3390/ijms242417398
|
| 20 |
Laurence Verneuil, Christophe Leboeuf, Guilhem Bousquet, Charlotte Brugiere, Morad Elbouchtaoui, Louis-François Plassa, Marie-Noelle Peraldi, Celeste Lebbé, Philippe Ratajczak, Anne Janin. Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients. Oncotarget 2015; 6(39): 41497 doi: 10.18632/oncotarget.6359
|
| 21 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 2625 doi: 10.1007/978-3-319-26956-6_147
|
| 22 |
Ming-Tai Hu, Jing-Han Wang, Yong Yu, Chen Liu, Bin Li, Qing-Bao Cheng, Xiao-Qing Jiang. Tumor suppressor LKB1 inhibits the progression of gallbladder carcinoma and predicts the prognosis of patients with this malignancy. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4466
|
| 23 |
Alice Agliano, Alfonso Calvo, Carol Box. The challenge of targeting cancer stem cells to halt metastasis. Seminars in Cancer Biology 2017; 44: 25 doi: 10.1016/j.semcancer.2017.03.003
|
| 24 |
Hong Wu, Xiao-wei Qi, Guang-ning Yan, Qing-bi Zhang, Chuan Xu, Xiu-wu Bian, William B. Coleman. Is CD133 Expression a Prognostic Biomarker of Non-Small-Cell Lung Cancer? A Systematic Review and Meta-Analysis. PLoS ONE 2014; 9(6): e100168 doi: 10.1371/journal.pone.0100168
|
| 25 |
Bettina Reissenweber, Birgit Mosch, Jens Pietzsch. Experimental hypoxia does not influence gene expression and protein synthesis of Eph receptors and ephrin ligands in human melanoma cells in vitro. Melanoma Research 2013; 23(2): 85 doi: 10.1097/CMR.0b013e32835e58f3
|
| 26 |
Ting-Ting Gu, Shu-Yan Liu, Peng-Sheng Zheng. Cytoplasmic NANOG-Positive Stromal Cells Promote Human Cervical Cancer Progression. The American Journal of Pathology 2012; 181(2): 652 doi: 10.1016/j.ajpath.2012.04.008
|
| 27 |
Chi Liang, Pinghua Yang, Tao Han, Ruo-Yu Wang, Xiang-Lei Xing, An-Feng Si, Qian-Yun Ma, Zhong Chen, Heng-Yu Li, Baohua Zhang. Long non-coding RNA DILC promotes the progression of gallbladder carcinoma. Gene 2019; 694: 102 doi: 10.1016/j.gene.2018.12.086
|
| 28 |
Jakub Neradil, Renata Veselska. Nestin as a marker of cancer stem cells. Cancer Science 2015; 106(7): 803 doi: 10.1111/cas.12691
|
| 29 |
Jiwei Yu, Zhaohui Tang, Wei Gong, Mingdi Zhang, Zhiwei Quan. Isolation and identification of tumor‑initiating cell properties in human gallbladder cancer cell lines using the marker cluster of differentiation 133. Oncology Letters 2017; doi: 10.3892/ol.2017.7159
|
| 30 |
Christian Mayr, Matthias Ocker, Markus Ritter, Martin Pichler, Daniel Neureiter, Tobias Kiesslich. Biliary tract cancer stem cells - translational options and challenges. World Journal of Gastroenterology 2017; 23(14): 2470-2482 doi: 10.3748/wjg.v23.i14.2470
|
| 31 |
RALF KEMMERLING, BEATE ALINGER, OTTO DIETZE, HANS-CHRISTIAN BÖSMÜLLER, MATTHIAS OCKER, GERNOT W. WOLKERSDÖRFER, FRIEDER BERR, DANIEL NEUREITER, TOBIAS KIESSLICH. Association of stem cell marker expression pattern and survival in human biliary tract cancer. International Journal of Oncology 2012; 41(2): 511 doi: 10.3892/ijo.2012.1477
|
| 32 |
Chen Li, Cong Wang, Yang Xing, Jiaojiao Zhen, Zhilong Ai. CD133 promotes gallbladder carcinoma cell migration through activating Akt phosphorylation. Oncotarget 2016; 7(14): 17751 doi: 10.18632/oncotarget.7474
|
| 33 |
Ayaz Shahid, Mausumi Bharadwaj. The connection between the Th17 cell related cytokines and cancer stem cells in cancer: Novel therapeutic targets. Immunology Letters 2019; 213: 9 doi: 10.1016/j.imlet.2019.07.001
|
| 34 |
Archana Chaudhary, Syed Shadab Raza, Rizwanul Haque. Transcriptional factors targeting in cancer stem cells for tumor modulation. Seminars in Cancer Biology 2023; 88: 123 doi: 10.1016/j.semcancer.2022.12.010
|
| 35 |
XIANGMEI CAO, YU GU, LINA JIANG, YINGMEI WANG, FANG LIU, YUQIAO XU, JUNXIA DENG, YAYUN NAN, LIYING ZHANG, JING YE, QING LI. A new approach to screening cancer stem cells from the U251 human glioma cell line based on cell growth state. Oncology Reports 2013; 29(3): 1013 doi: 10.3892/or.2012.2206
|
| 36 |
Koangyong Sung, Kenji Hosoya, Yusuke Murase, Tatsuya Deguchi, Sangho Kim, Takafumi Sunaga, Masahiro Okumura. Visualizing the cancer stem‐like properties of canine tumour cells with low proteasome activity. Veterinary and Comparative Oncology 2022; 20(1): 324 doi: 10.1111/vco.12779
|